SPX -0.03% VIX -2.13%
LEAR CUTS SALES AND EARNINGS GUIDANCE 
U.S. IMPORT-PRICES DATA PROVIDE LATEST EVIDENCE OF WEAK INFLATION 
WELLS FARGO SHARES SLIP IN PREMARKET EVEN AS EARNINGS BLOW BY TARGET 
U.S. RETAIL SALES PICK UP MORE THAN FORECAST IN JUNE 
NEED TO KNOW: CORRELATION BETWEEN 10-YEAR NOTE AND S&P 500 CALLED 'EXTREME' 
ASSANGE TURNED EMBASSY IN LONDON INTO COMMAND POST FOR ELECTION ATTACK: CNN 
BLUE APRON SHARES RALLY ON ANNOUNCEMENT OF BEYOND MEAT RECIPES 
JOHNSON & JOHNSON SHARES UP IN PREMARKET AFTER EARNINGS TOP TARGET 
GOLDMAN SACHS SHARES ON RISE AFTER SECOND-QUARTER EARNINGS REPORT 
DOMINO'S PIZZA STOCK FALLS MORE THAN 5% AFTER EARNINGS REPORT 
Tue, Jul 16 10:16am

Compare BIIB



Biogen Inc [BIIB]
$233.63 0.01 (0.00%)

BIIB Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 44.87 Billion
BIIB Description

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Tysabri and Tecfidera. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.


Visit Website

BIIB Earnings

EPS 7.17 P/E Ratio 10.77
Previous Earnings Wed, Apr 24, 2019
Latest Earnings Tue, Jul 23, 2019 (In 7 days)

BIIB Dividend

Yield --
Ex-Date --
Pay Date --
History --

BIIB Charts

$216.49
52 Week Range
$388.67
Mar 22, 2019
Jul 25, 2018



Symbol Price Day % YTD %
BIIB $233.63 0.00% -23.32%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy